Skip to main content
ANVS
NYSE Life Sciences

Annovis Prices Nothing Yet: Preliminary Offering Adds Warrants to Every Share

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$0.94
Mkt Cap
$51.642M
52W Low
$0.93
52W High
$5.5
52W Position info
1.1% above low
Off High info
83% below high
Rel. Volume info
1.4× avg
Market data snapshot near publication time

ANVS is trading near its 52-week low of $0.93 (1.1% above the low).

Summary

Annovis filed a preliminary prospectus for an underwritten stock-and-warrant offering with all key terms — price, size, proceeds — still blank. The cash-poor, going-concern-flagged company is raising again while fighting an NYSE listing deficiency.


Key Events · Financing and Capital Events · ANVS

  • Underwritten Offering, Terms Unpriced

    Preliminary prospectus covers common stock (or pre-funded warrants) each bundled with one five-year warrant; offering price, share count and net proceeds are all left blank, so the deal size is not yet determined.

  • Warrant Overhang on Every Unit

    Each share or pre-funded warrant is sold with one warrant exercisable at a strike to be set at pricing, adding a second layer of potential dilution beyond the shares sold. Pre-funded warrants carry a $0.0001 exercise price.

  • Cash Position Is Thin

    Company estimates about $2,819,898 of cash at September 30, 2026, and states it does not have sufficient capital to fund operations for the next 12 months. Net tangible book value was approximately $(4,254,618), or $(0.10) per share, at June 30, 2026.

  • NYSE Deficiency Adds Pressure

    An October 29, 2026 NYSE notice flags non-compliance with Section 802.01B: 30-day average market cap of about $48.4 million against a $50 million threshold, with stockholders' deficit of about $(4.3) million at June 30, 2026. A compliance plan is due within 45 days.


Analysis · ANVS · Life Sciences

Annovis is back in the market for cash it badly needs — it had roughly $2.8 million at September 30 and has already told investors it cannot fund the next 12 months. The structure is the story: every share sold comes with a five-year warrant, so buyers get upside leverage and existing holders absorb dilution now plus a second wave if the warrants are exercised. Pricing, share count and proceeds are all blank, so the real cost of this capital is not yet known — and the stock closed at $1.09 on November 3, meaning the deal will likely be struck at a low absolute price. Layered on top: an NYSE notice on October 29 that the company fails the $50 million market-cap/equity standard, a going-concern opinion from its auditor, and a shareholder-approved doubling of authorized shares to 140 million that exists precisely to make this issuance possible.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 48.3% of the 2133 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.28%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, ANVS was trading at $0.94 on NYSE in the Life Sciences sector, with a market capitalization of approximately $51.6M. The 52-week trading range was $0.93 to $5.50. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

ANVS - Latest Insights

ANVS
Nov 17, 2026, 8:00 AM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $0.800
Real-time Price: $0.774 info
Change: -$0.026 (-3%) info
Market Cap: $46.418M info
ANVS
Nov 13, 2026, 4:24 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.940
Real-time Price: $0.774 info
Change: -$0.166 (-18%) info
Market Cap: $46.418M info
ANVS
Nov 06, 2026, 4:30 PM EST
Filing Type: 4
Importance Score:
8
Price at Filing: $0.8799
Real-time Price: $0.774 info
Change: -$0.1059 (-12%) info
Market Cap: $46.418M info
ANVS
Nov 05, 2026, 8:05 AM EST
Source: Wiseek News
Importance Score:
8
Price at Filing: $0.8689
Real-time Price: $0.774 info
Change: -$0.0949 (-11%) info
Market Cap: $46.418M info
ANVS
Nov 04, 2026, 4:07 PM EST
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $0.8507
Real-time Price: $0.774 info
Change: -$0.0767 (-9%) info
Market Cap: $46.418M info